| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.14B | 4.43B | 4.44B | 6.05B | 6.75B |
| Gross Profit | 559.40M | 529.41M | 321.99M | 577.82M | 879.54M |
| EBITDA | 297.80M | 252.01M | 339.40M | 204.77M | 549.24M |
| Net Income | 71.30M | 14.26M | 50.90M | -115.53M | 241.33M |
Balance Sheet | |||||
| Total Assets | 4.53B | 4.61B | 4.90B | 5.05B | 5.75B |
| Cash, Cash Equivalents and Short-Term Investments | 1.55B | 1.30B | 1.38B | 1.39B | 824.98M |
| Total Debt | 185.92M | 182.67M | 325.03M | 579.25M | 482.31M |
| Total Liabilities | 1.04B | 1.16B | 1.43B | 1.62B | 1.99B |
| Stockholders Equity | 3.25B | 3.24B | 3.27B | 3.22B | 3.56B |
Cash Flow | |||||
| Free Cash Flow | 263.46M | -25.39M | 195.00M | 741.49M | -372.07M |
| Operating Cash Flow | 372.67M | 151.70M | 293.76M | 905.63M | -210.39M |
| Investing Cash Flow | 36.20M | 11.07M | 1.86M | -136.63M | -148.77M |
| Financing Cash Flow | -159.21M | -242.52M | -309.90M | -171.40M | -64.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$16.86B | 10.93 | 14.30% | 5.87% | 6.88% | 11.98% | |
72 Outperform | HK$910.27M | 5.23 | 5.84% | 6.04% | -1.81% | -2.23% | |
71 Outperform | HK$67.95B | 14.19 | 15.53% | 4.31% | 8.19% | -6.72% | |
63 Neutral | HK$882.02M | 10.31 | 1.70% | 1.90% | -6.55% | 401.72% | |
63 Neutral | HK$2.19B | 1.51 | 15.14% | 12.14% | -0.95% | 2.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | HK$439.50M | 6.47 | -14.53% | ― | -5.61% | ― |